3 ms·
I've actually run into a very similar example, I was prescribed a $400 dollar bottle of antibiotic eye drops, which my insurance fought and eventually paid for.
by darpa_escapee 9y ago
I've actually run into a very similar example, I was prescribed a $400 dollar bottle of antibiotic eye drops, which my insurance fought and eventually paid for. I asked why that was chosen and if there were other options that I could pursue in the future. I was told that "these are your eyes and I'm not going to [fuck around] when it comes to your vision."
I can't really disagree with that logic.
- cko 9y agoTrue, but what did doctors do before these new drugs? “Fuck around” with “inferior” products... reason I’m cynical is because many new drugs that hit the market are not novel - for example loteprednol (older drug) vs difluprednate (newer): https://www.ncbi.nlm.nih.gov/m/pubmed/28628490/ https://www.ncbi.nlm.nih.gov/m/pubmed/28628490/ By the way, some of these newer drugs don’t have to be “superior” to be approved, they just have to be none-inferior to current therapy. https://www.raps.org/regulatory-focus™/news-articles/2016/11/when-can-non-inferiority-trials-establish-efficacy-fda-explains-with-guidance https://www.raps.org/regulatory-focus™/news-articles/2016/11...
- darpa_escapee 9y agoFrom what I gathered, it was more effective than the cheaper options, not that it was chosen because it was new and shiny.